What People Aged 50 and Older Need to Know About Flu Shots
By Emma Carter
Image information
This is a representative image for this Daily News lesson.
Intro
With flu activity reportedly increasing earlier than usual, an infectious-disease specialist explains the differences between a new RNA vaccine and traditional flu shots, as well as why production methods affect how quickly vaccines can be prepared.
Vocabulary
| Word | Part of speech | Meaning | Example |
|---|---|---|---|
| substantial adjective | adjective | Meaning: considerable in amount, degree, or importance | Example: The project requires substantial preparation before implementation. |
| timetable noun | noun | Meaning: a planned schedule indicating when stages or events should occur | Example: The research team revised its timetable after the preliminary results arrived. |
| circulate verb | verb | Meaning: to spread or move among people, places, or systems | Example: Officials monitored which rumors continued to circulate online. |
| antigen noun | noun | Meaning: a substance that triggers an immune response, especially antibody production | Example: Researchers identified an antigen that could stimulate a targeted immune response. |
| flexibility noun | noun | Meaning: the capacity to adapt readily to changing conditions or requirements | Example: The program offers flexibility when participants' circumstances change. |
| formulations noun | noun | Meaning: distinct compositions or versions of a preparation designed for a particular purpose | Example: The company tested several formulations before selecting one for clinical trials. |
| considerably adverb | adverb | Meaning: to a notably large extent or degree | Example: The revised policy considerably reduced delays in processing applications. |
The story
Flu activity is rising earlier than usual, according to the Centers for Disease Control and Prevention, but vaccination is still possible. In an NPR interview, host Ayesha Rascoe asks infectious-disease specialist Dr. Ann Falsey what people aged 50 and older should understand about the range of flu vaccines now available, including one described as new that year.
The conversation focuses on how the newer vaccine is made. Falsey explains that it uses RNA technology, the same broad approach associated with COVID-19 vaccines. Rather than delivering a piece of the virus directly, an RNA vaccine provides the body with instructions, or a message, to produce a protein. The immune system then reacts to that protein.
Traditional flu vaccines work differently. Manufacturers generally grow viral components in chicken eggs or in large containers of cells. Before production begins, they must estimate which flu strains are most likely to circulate during the winter. This preparation is necessary because producing enough vaccine through these methods can take substantial time.
Falsey says the process, particularly when chicken eggs are used, can require six to nine months of advance planning. That timetable means manufacturers must make predictions well before the flu season fully develops. If the strains that circulate later differ from those expected, adjusting production can be difficult.
RNA technology may offer greater flexibility. Once manufacturers select an antigen—the protein targeted by the immune response—they can produce the RNA-based material relatively quickly. According to Falsey, this could make it easier to adapt to a new flu strain that emerges and to increase production more rapidly, potentially making additional doses available sooner.
The interview presents the technology as a difference in vaccine production, not as a reason to ignore established options. For older adults considering vaccination, its central message is that several formulations exist, while the science behind them can vary considerably. Understanding that distinction may help people follow discussions about seasonal flu protection with greater clarity.
Warm-up questions
- What factors might influence your choice among different vaccine options?
- Why could production speed matter when a seasonal virus changes unexpectedly?
Comprehension questions
- What does the RNA vaccine provide to the body instead of delivering directly?
- Why must traditional vaccine manufacturers predict circulating strains in advance?
- How long can the traditional production process require when chicken eggs are used?
- What potential advantage might RNA technology offer when a new strain emerges?
- What overall perspective does the interview present on established vaccines?
Opinion questions
- Would the possibility of faster adaptation influence your preference for a vaccine technology? Explain your reasoning.
- How important is it for public-health communication to distinguish production methods from vaccine effectiveness?
Further discussion
- What institutional or logistical barriers could limit the practical benefits of faster vaccine production?
- How might uncertainty about future strains affect decision-making by manufacturers and individuals?
Writing prompt
- Write a 220-word analytical response explaining how production technology can shape seasonal vaccine availability and public decision-making.
